China Regenerative Medicine (08158) announced the results for the nine months ended September 30, 2023, with revenue of 112 million...
Zhitong Finance App News, China Regenerative Medicine (08158) released results for the nine months ended September 30, 2023, with revenue of HK$112 million, down 31.3% year on year; net profit of HK$6.677 million, down 36.7% year on year; and basic profit per share of HK$2.34 cents.
The overall decline in revenue was mainly due to a slight decrease in the number of Chinese customers visiting the company center to select various health and beauty services in the third quarter of 2023 and the excellent performance of the company's designated service provider (Changzhou Starsky Medical Beauty Clinic Co., Ltd.) in the third quarter of 2022.